First National Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.41M Sell
9,868
-1,975
-17% -$460K 0.35% 79
2025
Q4
$2.45M Sell
11,843
-1,506
-11% -$298K 0.34% 81
2025
Q3
$2.48M Sell
13,349
-583
-4% -$99.9K 0.34% 85
2025
Q2
$2.13M Buy
13,932
+163
+1% +$25.1K 0.31% 101
2025
Q1
$2.28M Sell
13,769
-5,295
-28% -$828K 0.37% 87
2024
Q4
$2.76M Buy
19,064
+527
+3% +$81.7K 0.45% 73
2024
Q3
$3M Buy
18,537
+584
+3% +$93K 0.48% 64
2024
Q2
$2.62M Buy
17,953
+1,142
+7% +$170K 0.48% 65
2024
Q1
$2.65M Buy
16,811
+4,064
+32% +$647K 0.59% 52
2023
Q4
$2M Buy
12,747
+2,724
+27% +$418K 0.58% 62
2023
Q3
$1.56M Buy
10,023
+5,642
+129% +$931K 0.7% 47
2023
Q2
$725K Buy
4,381
+1,045
+31% +$169K 0.67% 54
2023
Q1
$517K Sell
3,336
-223
-6% -$36K 0.59% 63
2022
Q4
$629K Buy
3,559
+110
+3% +$19K 0.81% 47
2022
Q3
$563K Buy
3,449
+679
+25% +$115K 0.83% 42
2022
Q2
$492K Buy
+2,770
New +$494K 1.02% 36

Other funds holding JNJ

First National Advisers's JNJ Position: Q1 2026 in Review

First National Advisers reduced its Johnson & Johnson (JNJ) stake by 17% in Q1 2026, selling an estimated $460K and leaving 9,868 shares worth $2.41M. The position accounts for 0.35% of the portfolio, ranked #79.

First National Advisers first reported a position in JNJ in Q2 2022 and has held it in 16 quarters since. The position peaked at $3M in Q3 2024. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • First National Advisers held 9,868 shares of Johnson & Johnson worth $2.41M as of Q1 2026.
  • First National Advisers sold 1,975 Johnson & Johnson shares in Q1 2026, an estimated $460K.
  • Johnson & Johnson made up 0.35% of First National Advisers's portfolio in Q1 2026, its #79 holding.
  • First National Advisers first reported a position in Johnson & Johnson in Q2 2022 and has held it in 16 quarters since.
  • First National Advisers's Johnson & Johnson position peaked at $3M in Q3 2024.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on First National Advisers's 13F filing for Q1 2026, filed 8 May 2026.